Colorectal Cancer-Specific Cytochrome P450 2W1: Intracellular Localization, Glycosylation, and Catalytic Activity

@article{Gomez2010ColorectalCC,
  title={Colorectal Cancer-Specific Cytochrome P450 2W1: Intracellular Localization, Glycosylation, and Catalytic Activity},
  author={Alvin V. Gomez and Jana Nekvindov{\'a} and Sandra Travica and Mi-Young Lee and Inger Johansson and David Edler and Souren Mkrtchian and Magnus Ingelman-Sundberg},
  journal={Molecular Pharmacology},
  year={2010},
  volume={78},
  pages={1004 - 1011}
}
Cytochrome P450 2W1 (CYP2W1) is expressed at high levels in colorectal cancer cells. Moreover, we have shown previously that a higher tumor expression is associated with less survival. In this study, we characterize post-translational modification, inverted endoplasmic reticulum (ER) topology, and catalytic activity of CYP2W1. The analysis of colorectal normal and cancer tissues and CYP2W1 overexpressing human embryonic kidney (HEK) 293 cells showed that a fraction of CYP2W1 is modified by N… 

Figures from this paper

Colon Cancer Specific Cytochrome P 450 2 W 1 : Polymorphism , Membrane Topology and Endogenous Roles in Development

The characterized polymorphic variants of CYP2W1 are characterized and no significant correlation between their distribution and CRC risk is found and this study strongly supports the atypical membrane topology of CY P450 2W1 and suggests the interaction with redox partner yet to be identified in the ER lumen in a potential role in gut development.

The CYP2W1 enzyme: regulation, properties and activation of prodrugs

The CRC specific localization of CYP2W1 and its effective prodrug activation makes it a very promising target for future development of cancer therapeutics.

Colon Cancer–Specific Cytochrome P450 2W1 Converts Duocarmycin Analogues into Potent Tumor Cytotoxins

A novel approach for treatment of colon cancer that uses a locoregional activation of systemically inactive prodrug by the tumor-specific activator enzyme CYP2W1 is suggested.

Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas

It is concluded that normal adrenal tissue lacks P450 2W1 enzyme expression; also, adrenocortical carcinomas generally do not express the enzyme, underline the colon cancer specificity of CYP2W1 enzymes expression.

Membrane topology and search for potential redox partners of colon cancer‐specific cytochrome P450 2W1

The reduced catalytic activity of the Asn177 mutant that is modified by glycan moieties in the wild‐type enzyme indicates a functional relevance of CYP2W1 glycosylation.

Cytochrome P450 2W1 (CYP2W1) – ready for use as the biomarker and drug target for cancer?

  • Yan PanE. Ong
  • Biology
    Xenobiotica; the fate of foreign compounds in biological systems
  • 2017
Catalytic activity of CYP2W1 should be tested on a wider spectrum of endogenous and exogenous substances before its use as the drug target of cancer because of its characteristic cancer-specific expression.

The expression of CYP2W1: a prognostic marker in colon cancer.

The results of the current study were in agreement with those of the previous pilot study and show that higher expression of CYP2W1 seems to be of prognostic value in colon cancer.

Cancer Therapy : Preclinical Colon Cancer – Speci fi c Cytochrome P 450 2 W 1 Converts Duocarmycin Analogues into Potent Tumor Cytotoxins

A novel approach for treatment of colon cancer that uses a locoregional activation of systemically inactive prodrug by the tumor-specific activator enzyme CYP2W1 is suggested.

References

SHOWING 1-10 OF 36 REFERENCES

Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.

Molecular Basis for the Transport of Cytochrome P450 2E1 to the Plasma Membrane*

The molecular basis for the transport of rat ethanol-inducible cytochrome P450 2E1 (CYP2E1) to the plasma membrane was investigated by transfection of several different mutant cDNAs into mouse H2.35 hepatoma cells and it was concluded that the NH2-terminal transmembrane domain of CYP2E 1 plays a critical role in directing the protein to the cell surface.

Functional Characterization of Human Cytochrome P450 2S1 Using a Synthetic Gene-Expressed Protein in Escherichia coli

It is found that CYP2S1 contributes to the metabolism of environmental carcinogens via an NADPH independent activity and is overexpressed in Escherichia coli using a synthetic gene approach.

Enzymatic properties of human CYP2W1 expressed in Escherichia coli.

Mobility of cytochrome P450 in the endoplasmic reticulum membrane.

The mobilities of cytochrome P450 in the ER membrane were determined by recovery of fluorescence after photobleaching, and data indicate that exclusion from the recycling pathway is not mediated by immobilization in large protein complexes.

Cytochrome P450 proteins: retention and distribution from the endoplasmic reticulum.

The mechanisms of intracellular CYP transport, and the implications of the presence of CYP proteins in extra-ER compartments for drug metabolism and toxicity are discussed.

Expression of CYP2W1 in colon tumors: regulation by gene methylation.

The expression of CYP2W1 is colon tumor-specific and is associated with methylation status of the CYP1W1 gene, suggesting a potential causal link between the gene hypomethylation and its enhanced expression.

Acetone-regulated synthesis and degradation of cytochrome P4502E2 and cytochrome P4502B1 in rat liver

The data suggest that CYP2E1 is acutely inactivated in the endoplasmic reticulum and that degradation of this isozyme occurs, at least in part, by the lysosomal route, whereas CYP 2B1 is principally controlled at the level of synthesis.

Recombinant Enzymes Overexpressed in Bacteria Show Broad Catalytic Specificity of Human Cytochrome P450 2W1 and Limited Activity of Human Cytochrome P450 2S1

The bioactivation of procarcinogens by cytochrome P450 2W1 may be of significance in the context of reports of preferential expression of the enzyme in tumors, in that activation of procARCinogens could lead to the accumulation of mutations and enhance the carcinogenic process.

Mitochondrial P450s.

  • T. Omura
  • Biology, Chemistry
    Chemico-biological interactions
  • 2006